Tolerability of Aminosalicylates in Inflammatory Bowel Disease

By Ishaq S.  

BioDrugs, Vol. 15, Iss. 5, 2001-05 ,pp. : 339-349

Adis International

Access to resources Recommend Favorite

Probiotiques et maladies inflammatoires chroniques de l’intestin : essais contrôlés et perspectives: Probiotics in Inflammatory Bowel Disease: Controlled Trials and Perspectives

By Seksik Philippe   Marteau Philippe  

Therapie, Vol. 59, Iss. 1, 2004-01 ,pp. : 83-87

Adis International

Access to resources Recommend Favorite

Targeting of Costimulatory Molecules as a Therapeutic Approach in Inflammatory Bowel Disease

By Maerten P.  

BioDrugs, Vol. 17, Iss. 6, 2003-01 ,pp. : 395-411

Adis International

Access to resources Recommend Favorite

Sphingomyelinase Inhibition Suggests a Possible New Strategy for the Treatment of Inflammatory Bowel Disease

By  

Current Drug Therapy, Vol. 3, Iss. 3, 2008-09 ,pp. : 218-225

Bentham Science Publishers

Access to resources Recommend Favorite

State of the Art: Therapeutical Strategies for the Treatment of Inflammatory Bowel Disease

By  

Current Drug Therapy, Vol. 8, Iss. 2, 2013-06 ,pp. : 99-120

Bentham Science Publishers

Access to resources Recommend Favorite